Creatine Kinase Elevation in Patients with Autosomal Dominant Polycystic Kidney Disease on Tolvaptan Treatment

被引：0
|
作者：
Rodriguez-Espinosa, Diana [1 ]
Payan, Elena C. [1 ]
Guillen, Elena [1 ]
Blasco Pelicano, Josep Miquel [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1205
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [41] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
    Higashihara, Eiji
    Torres, Vicente E.
    Chapman, Arlene B.
    Grantham, Jared J.
    Bae, Kyongtae
    Watnick, Terry J.
    Horie, Shigeo
    Nutahara, Kikuo
    Ouyang, John
    Krasa, Holly B.
    Czerwiec, Frank S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10): : 2499 - 2507
  • [42] Autosomal Dominant Polycystic Kidney Disease Inflammation Biomarkers in the Tolvaptan Era
    Lapao, Tania
    Barata, Rui
    Jorge, Cristina
    Flores, Carlos
    Calado, Joaquim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [43] Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
    Gittus, Matt
    Haley, Helen
    Harris, Tess
    Borrows, Sarah
    Padmanabhan, Neal
    Gale, Danny
    Simms, Roslyn
    Williams, Terri
    Acquaye, Aaron
    Wong, Alisa
    Chan, Melanie
    Lee, Eduardo
    Ong, Albert C. M.
    BMC NEPHROLOGY, 2025, 26 (01)
  • [44] Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
    Blanchette, Christopher M.
    Gutierrez, Benjamin
    Friend, Keith
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (02) : 142 - 143
  • [45] Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
    Erickson, Kevin F.
    Chertow, Glenn M.
    Goldhaber-Fiebert, Jeremy D.
    ANNALS OF INTERNAL MEDICINE, 2013, 159 (06) : 382 - +
  • [46] Tolvaptan and Number Needed to Harm in Autosomal Dominant Polycystic Kidney Disease
    Betts, Keith A.
    Nunna, Sasikiran
    Kumar, Retesh
    Nie, Xiaoyu
    Fernandes, Ancilla W.
    KIDNEY MEDICINE, 2024, 6 (04)
  • [47] Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Perrone, Ronald D.
    Koch, Gary
    Ouyang, John
    McQuade, Robert D.
    Blais, Jaime D.
    Czerwiec, Frank S.
    Sergeyeva, Olga
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1930 - 1942
  • [48] Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease
    Naranjo, Javier
    Borrego, Francisco
    Rocha, Jose Luis
    Salgueira, Mercedes
    Adoracion Martin-Gomez, Maria
    Orellana, Cristhian
    Morales, Ana
    Vallejo, Fernando
    Hidalgo, Pilar
    Rodriguez, Francisca
    Garofano, Remedios
    Gonzalez, Isabel
    Esteban, Rafael
    Espinosa, Mario
    FRONTIERS IN MEDICINE, 2022, 9
  • [49] SMALL TOTAL KIDNEY VOLUME IS COLLERATED WITH EFFECT OF TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS
    Kawashima, Keisuke
    Nishio, Saori
    Kondo, Keiichi
    Ishikawa, Yozo
    Hattanda, Fumihiko
    Makita, Minoru
    Kusunoki, Yoshihiro
    Matsuoka, Naoko
    Yamamoto, Junya
    Nakagaki, Tasuku
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 96 - 96
  • [50] Pelvic organ prolapse in women with autosomal dominant polycystic kidney disease under tolvaptan treatment
    Sango, Cristina
    Bueno, Maria del Carmen Merino
    Perez, Anna Gallardo
    Martinez, Noelia Perez
    Gonzalez, Jaime Gutierrez
    Zorrilla, Carlos Ruiz
    Torre-Fernandez, Miguel de la
    Laures, Ana Maria Suarez
    Sanchez-Alvarez, Emilio
    NEFROLOGIA, 2023, 43 (06): : 791 - 792
12345